NASDAQ
Capricor Therapeutics, Inc. (CAPR) has a price/fcf ratio of -0.02x as of Monday, May 25, 2026. This represents a 100.18% decrease compared to its 12-month average of 10.17x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.